Headlines

IBOVESPA Bullish By 6% In The Last 21 Sessions

(VIANEWS) – IBOVESPA (BVSP) has been up by 6.93% for the last 21 sessions. At 09:08 EST on Thursday, 2 February, IBOVESPA (BVSP) is $112,634.47.

Concerning IBOVESPA’s yearly highs and lows, it’s 18.23% up from its 52-week low and 7.39% down from its 52-week high.

Volatility

IBOVESPA’s last week, last month’s, and last quarter’s current intraday variation average was 0.38%, 0.28%, and 1.33%, respectively.

IBOVESPA’s highest amplitude of average volatility was 1.21% (last week), 1.19% (last month), and 1.33% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IBOVESPA’s is considered to be overbought (>=80).

News about

  • According to FXStreet on Tuesday, 31 January, "While portraying the mood, the S&P 500 Futures print mild gains despite downbeat Wall Street performance whereas the US 10-year Treasury yields remain unchanged at around 3.55% after posting a three-day winning streak in the last."
  • According to FXStreet on Tuesday, 31 January, "Amid these plays, the S&P 500 Futures print mild gains despite downbeat Wall Street performance whereas the US 10-year Treasury yields remain unchanged at around 3.55% after posting a three-day winning streak in the last."
  • According to MarketWatch on Tuesday, 31 January, "Based on Monday’s stock closing price of $176.97, the new annual dividend rate implies a dividend yield of 3.66%, which compares with rival FedEx Corp.’s current yield of 2.50% and the implied yield for the S&P 500 of 1.69%. ", "The stock has lost 12.5% over the past 12 months through Monday, while FedEx shares have dropped 25.1% and the S&P 500 has shed 11.0%."
  • According to FXStreet on Tuesday, 31 January, "Against this backdrop, the S&P 500 Futures print mild gains despite downbeat Wall Street performance whereas the US 10-year Treasury yields remain unchanged at around 3.55% after posting a three-day winning streak in the last."

More news about IBOVESPA (BVSP).

Leave a Reply

Your email address will not be published. Required fields are marked *